The aerobic glycolysis driven by SLC2A3 not only enhances tumor cell aggressiveness but also initiates a feedback loop that contributes to glucose deficiency in the tumor microenvironment, thereby regulating the inflammatory state of the TME. This evidence concerns the gene SLC2A3 and neoplasm.